We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Complains to U.S. Trade Chief on EU Transparency Plan
PhRMA Complains to U.S. Trade Chief on EU Transparency Plan
PhRMA has asked the Office of the United States Trade Representative to put the EU on notice for its plan to publish clinical trial data that currently is treated as confidential.